Nanopublications

@prefix orcid: <https://orcid.org/> .
@prefix this: <http://purl.org/np/RAawm-aFsVya5KjD3tqxJLybxpsX-434ijIcM-Nuhy85M> .
@prefix sub: <http://purl.org/np/RAawm-aFsVya5KjD3tqxJLybxpsX-434ijIcM-Nuhy85M#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix ns2: <http://twoc-nlp-database-server-1:8555/solr/triples/select?q=> .
@prefix ns1: <https://uts.nlm.nih.gov/uts/umls/concept/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix ns3: <http://twoc-nlp-database-server-1:8555/solr/predicates/select?q=> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubInfo ;
    a np:Nanopublication .
}

sub:assertion {
  sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" .
  sub:version prov:value 1 .
  rdf:object ns1:C0030705 "patients" ;
    ns1:C0035647 "risk" ;
    ns1:C0038954 "survival rates" ;
    ns1:C0184661 "intervention" ;
    ns1:C0424295 "hyper" ;
    ns1:C0886296 "intervention" ;
    ns1:C1155266 "inflammatory response" ;
    ns1:C1273869 "intervention" ;
    ns1:C1280519 "effective" ;
    ns1:C1704419 "effective" ;
    ns1:C4552904 "risk" ;
    ns1:C5203670 "COVID-19" .
  rdf:predicate ns3:TRIPLE_UID:wm11rufi-TRIPLE-ABSTRACT-6 "be" .
  rdf:subject ns1:C0001617 "corticosteroid" ;
    ns1:C0011777 "dexamethasone" ;
    ns1:C0025815 "methylprednisolone" ;
    ns1:C0034107 "pulse" ;
    ns1:C0087111 "therapy" ;
    ns1:C0232117 "pulse" ;
    ns1:C0391850 "pulse" ;
    ns1:C0444956 "high dose" ;
    ns1:C1363945 "therapy" ;
    ns1:C1947910 "pulse" ;
    ns1:C3536709 "corticosteroid" ;
    ns1:C3844638 "either" .
  rdfs:Triple-UID ns2:TRIPLE_UID:wm11rufi-TRIPLE-ABSTRACT-6 "wm11rufi-TRIPLE-ABSTRACT-6" .
  rdfs:sentence rdfs:label "high dose corticosteroid pulse therapy (HDCPT) with either methylprednisolone or dexamethasone can be an effective intervention to increase COVID-19 survival rates in patients at risk of developing a COVID-19 hyper-inflammatory response, laboratory marker tests can be used to stratify these patients." .
  rdfs:triple rdfs:label "high dose corticosteroid pulse therapy ( HDCPT ) with either methylprednisolone or dexamethasone be an effective intervention to increase COVID-19 survival rates in patients at risk of developing a COVID-19 hyper - inflammatory response" .
}

sub:provenance {
sub:assertion prov:generatedAtTime "2021-07-25T21:46:17.902907"^^xsd:dateTime .
}

sub:pubInfo {
  sub:sig npx:hasAlgorithm "RSA" ;
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB" ;
    npx:hasSignature "bAYwd7FUI7lclcdY6itp3bHTu2al9dG/eAKRAtnAzZuWYt39ax6krZerMBOy+OyujuV3TouJWuU4z7sc9sVJIK0IUwsiI0Ub7e7/Gx7qR21cHZPSgJPiasZCl60NRuaLtPpgnMW4nz6IdbQDbWhTIZ0XGWAl4TAJInFaciv9coQ=" ;
    npx:hasSignatureTarget this: .
  this: prov:generatedAtTime "2021-07-25T21:46:17.902907"^^xsd:dateTime ;
    prov:wasAttributedTo orcid:0000-0002-8954-0470 .
}